senicapoc has been researched along with Disease Models, Animal in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Derseh, HB; Dewage, SNV; Koumoundouros, E; Organ, L; Pagel, CN; Perera, KUE; Snibson, KJ | 1 |
Bora, N; Bora, PS; Dasso, M; Lyzogubov, V | 1 |
Cil, O; Duan, T; Thiagarajah, JR; Verkman, AS | 1 |
Barcham, G; Barker, D; Bradding, P; Castle, N; Koumoundouros, E; Snibson, K; Sum, G; Van Der Velden, J; Wulff, H | 1 |
Bacci, B; Bradding, P; Jaffar, J; Kimpton, WG; Koumoundouros, E; Nowell, CJ; Organ, L; Roach, KM; Samuel, CS; Snibson, KJ; Westall, G | 1 |
5 other study(ies) available for senicapoc and Disease Models, Animal
Article | Year |
---|---|
K
Topics: Acetamides; Animals; Bleomycin; Cell Proliferation; Disease Models, Animal; Endothelial Cells; Female; Gene Expression Regulation; Intermediate-Conductance Calcium-Activated Potassium Channels; Lung; Pulmonary Fibrosis; Sheep; Trityl Compounds; Vascular Endothelial Growth Factor A; Vascular Remodeling | 2019 |
Role of thalidomide, senicapoc, and sodium butyrate in choroidal neovascularization.
Topics: Acetamides; Angiogenesis Inhibitors; Animals; Butyric Acid; Cell Line; Cell Proliferation; Choroidal Neovascularization; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred C57BL; Thalidomide; Trityl Compounds | 2020 |
Intestinal epithelial potassium channels and CFTR chloride channels activated in ErbB tyrosine kinase inhibitor diarrhea.
Topics: Acetamides; Afatinib; Animals; Cell Membrane Permeability; Clotrimazole; Colon; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; Disease Models, Animal; Epithelial Cells; ErbB Receptors; Female; Humans; Intestinal Mucosa; Neoplasms; Oxazines; Potassium Channel Blockers; Potassium Channels; Protein Kinase Inhibitors; Pyrimidinones; Pyrroles; Rats; Trityl Compounds | 2019 |
K(Ca)3.1 channel-blockade attenuates airway pathophysiology in a sheep model of chronic asthma.
Topics: Acetamides; Airway Remodeling; Airway Resistance; Animals; Asthma; Blood Vessels; Bronchoalveolar Lavage Fluid; Carbachol; Chronic Disease; Disease Models, Animal; Eosinophils; Female; Intermediate-Conductance Calcium-Activated Potassium Channels; Leukocyte Count; Lung; Mast Cells; Muscle, Smooth; Pyroglyphidae; Sheep; T-Lymphocytes; Trityl Compounds | 2013 |
Inhibition of the K
Topics: Acetamides; Animals; Bleomycin; Compliance; Disease Models, Animal; Fibroblasts; Fluorescent Antibody Technique; Intermediate-Conductance Calcium-Activated Potassium Channels; Lung; Pulmonary Fibrosis; Respiratory Function Tests; Sheep; Trityl Compounds | 2017 |